Tae Joong Kim
Overview
Explore the profile of Tae Joong Kim including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
17
Citations
148
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Kim N, Park W, Cho W, Bae D, Kim B, Lee J, et al.
J Gynecol Oncol
. 2021 Jun;
32(5):e72.
PMID: 34132070
Objective: Unlike cervical squamous cell carcinoma, there are no consensus criteria for serum tumor markers in cervical adenocarcinoma. This study aimed to identify the prognostic value of preoperative carbohydrate antigen...
2.
Jeong S, Kim T, Park B
J Gynecol Oncol
. 2020 Apr;
31(4):e57.
PMID: 32347021
Epithelial ovarian cancer has been traditionally treated with cytoreductive surgery and chemotherapy. Optimal surgery is the key to improving the prognosis, and, thus, preoperative imaging should be carefully assessed to...
3.
Jeong S, Choi C, Kim T, Lee J, Kim B, Bae D, et al.
J Ovarian Res
. 2020 Jan;
13(1):1.
PMID: 31892329
Background: Secondary cytoreductive surgery (SCS) is possible in selected patients with recurrent epithelial ovarian cancer (EOC). The goal of SCS is complete resection, although chemotherapy is always followed. Delayed intervals...
4.
Jeong S, Park H, Kim M, Kang J, Paik E, Lee Y, et al.
Cancer Res Treat
. 2019 Nov;
52(2):516-523.
PMID: 31671937
Purpose: Lymph node metastasis (LNM) is the most significant prognostic factor in cervical cancer that was recently incorporated into the International Federation of Gynecology and Obstetrics (FIGO) staging system. This...
5.
Paik E, Lee J, Park J, Kim J, Kim M, Kim T, et al.
J Gynecol Oncol
. 2019 May;
30(4):e65.
PMID: 31074247
Objectives: The aim of this study was to develop a new prognostic classification for epithelial ovarian cancer (EOC) patients using gradient boosting (GB) and to compare the accuracy of the...
6.
Kim J, Chang Y, Kim T, Lee J, Kim B, Bae D, et al.
J Gynecol Oncol
. 2018 Nov;
30(1):e11.
PMID: 30479095
Objective: Elderly age is one of the poor prognostic factors in epithelial ovarian cancer (EOC), but the optimal age cut-off is not known. The present study sought to identify the...
7.
Paik E, Kim T, Choi C, Kim B, Bae D, Lee J
J Gynecol Oncol
. 2018 Feb;
29(2):e18.
PMID: 29400011
Objective: The aim of this investigation is to compare outcomes of patients according to the presence of cancer arising from endometriosis in ovarian clear cell carcinoma (CCC) and endometrioid carcinoma...
8.
Paik E, Kim J, Kim T, Lee J, Kim B, Bae D, et al.
J Gynecol Oncol
. 2017 Nov;
29(1):e13.
PMID: 29185271
Objective: We compared survival outcomes of advanced serous type epithelial ovarian cancer (EOC) patients with normal-sized ovaries and enlarged-ovarian tumors by propensity score matching analysis. Methods: The medical records of...
9.
Nam S, Choi H, Kang W, Kim S, Lim M, Park S, et al.
J Korean Med Sci
. 2016 Nov;
31(12):1969-1975.
PMID: 27822937
Given the growing number of cancer patients and the resulting increase in the administration of chemotherapeutic agents, convenient and effective methods for measuring the symptoms and quality of life associated...
10.
Paik E, Kim T, Lee Y, Choi C, Lee J, Kim B, et al.
J Gynecol Oncol
. 2016 Jun;
27(5):e46.
PMID: 27329194
Objective: The aim of this study was to compare survival outcomes in two groups of patients with recurrent epithelial ovarian cancer (EOC) with initial recurrence detection by cancer antigen 125...